Literature DB >> 1707522

The use of engineered E1A genes to transactivate the hCMV-MIE promoter in permanent CHO cell lines.

M I Cockett1, C R Bebbington, G T Yarranton.   

Abstract

Vectors expressing adenovirus 5 E1A or a domain 2 mutant E1A were introduced into CHO-K1 cells in order to transactivate the hCMV-MIE promoter in transient and stable transfections. Expression from the hCMV promoter was efficiently activated by both wild-type and mutant E1A in contrast to other viral promoters such as the SV40 early promoter which are repressed by E1A. E1A genes expressed from a strong promoter were inhibitory to the growth of CHO cells. Nevertheless, by the use of a weaker promoter, it was possible to isolate stably transfected cell lines containing a level of E1A compatible with both continued cell growth and significant transactivation of the hCMV promoter. By this means we have generated cell lines secreting tissue inhibitor of metalloproteinases (TIMP) at levels approaching those previously attained using gene amplification. CHO cell lines constitutively expressing wild-type and mutant E1A genes have been derived which can serve as new host cell lines for transient expression and efficient stable expression without gene amplification.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1707522      PMCID: PMC333597          DOI: 10.1093/nar/19.2.319

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  25 in total

1.  The repression of the growth factor-inducible genes JE, c-myc and stromelysin by adenovirus E1A is mediated by conserved region 1.

Authors:  H van Dam; R Offringa; A M Smits; J L Bos; N C Jones; A J van der Eb
Journal:  Oncogene       Date:  1989-10       Impact factor: 9.867

2.  Comparison of human stromelysin and collagenase by cloning and sequence analysis.

Authors:  S E Whitham; G Murphy; P Angel; H J Rahmsdorf; B J Smith; A Lyons; T J Harris; J J Reynolds; P Herrlich; A J Docherty
Journal:  Biochem J       Date:  1986-12-15       Impact factor: 3.857

3.  Transient gene expression control: effects of transfected DNA stability and trans-activation by viral early proteins.

Authors:  J C Alwine
Journal:  Mol Cell Biol       Date:  1985-05       Impact factor: 4.272

4.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

Authors:  F L Graham; J Smiley; W C Russell; R Nairn
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

5.  Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family.

Authors:  P Fort; L Marty; M Piechaczyk; S el Sabrouty; C Dani; P Jeanteur; J M Blanchard
Journal:  Nucleic Acids Res       Date:  1985-03-11       Impact factor: 16.971

6.  A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus.

Authors:  M Boshart; F Weber; G Jahn; K Dorsch-Häsler; B Fleckenstein; W Schaffner
Journal:  Cell       Date:  1985-06       Impact factor: 41.582

7.  Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity.

Authors:  A J Docherty; A Lyons; B J Smith; E M Wright; P E Stephens; T J Harris; G Murphy; J J Reynolds
Journal:  Nature       Date:  1985 Nov 7-13       Impact factor: 49.962

8.  Amplified expression constructs for human tissue-type plasminogen activator in Chinese hamster ovary cells: instability in the absence of selective pressure.

Authors:  U H Weidle; P Buckel; J Wienberg
Journal:  Gene       Date:  1988-06-30       Impact factor: 3.688

9.  Characterization and novel purification of recombinant human protein C from three mammalian cell lines.

Authors:  S C Yan; P Razzano; Y B Chao; J D Walls; D T Berg; D B McClure; B W Grinnell
Journal:  Biotechnology (N Y)       Date:  1990-07

10.  Immunoassays for the detection of human collagenase, stromelysin, tissue inhibitor of metalloproteinases (TIMP) and enzyme-inhibitor complexes.

Authors:  S Cooksley; J B Hipkiss; S P Tickle; E Holmes-Ievers; A J Docherty; G Murphy; A D Lawson
Journal:  Matrix       Date:  1990-10
View more
  9 in total

1.  A specific alpha5beta1-integrin conformation promotes directional integrin translocation and fibronectin matrix formation.

Authors:  Katherine Clark; Roumen Pankov; Mark A Travis; Janet A Askari; A Paul Mould; Susan E Craig; Peter Newham; Kenneth M Yamada; Martin J Humphries
Journal:  J Cell Sci       Date:  2004-12-22       Impact factor: 5.285

Review 2.  Large-scale transfection of mammalian cells for the fast production of recombinant protein.

Authors:  Phuong Lan Pham; Amine Kamen; Yves Durocher
Journal:  Mol Biotechnol       Date:  2006-10       Impact factor: 2.695

3.  Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imaging.

Authors:  Tove Olafsen; Vania E Kenanova; Gobalakrishnan Sundaresan; Anne-Line Anderson; Desiree Crow; Paul J Yazaki; Lin Li; Michael F Press; Sanjiv S Gambhir; Lawrence E Williams; Jeffrey Y C Wong; Andrew A Raubitschek; John E Shively; Anna M Wu
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

4.  The N-terminal end of the CH2 domain of chimeric human IgG1 anti-HLA-DR is necessary for C1q, Fc gamma RI and Fc gamma RIII binding.

Authors:  A Morgan; N D Jones; A M Nesbitt; L Chaplin; M W Bodmer; J S Emtage
Journal:  Immunology       Date:  1995-10       Impact factor: 7.397

5.  Characterization and polyanion-binding properties of purified recombinant prion protein.

Authors:  D B Brimacombe; A D Bennett; F S Wusteman; A C Gill; J C Dann; C J Bostock
Journal:  Biochem J       Date:  1999-09-15       Impact factor: 3.857

6.  Approaches to maximizing stable expression of alpha 1-antitrypsin in transformed CHO cells.

Authors:  T Paterson; J Innes; S Moore
Journal:  Appl Microbiol Biotechnol       Date:  1994-01       Impact factor: 4.813

7.  Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector.

Authors:  G W Wilkinson; A Akrigg
Journal:  Nucleic Acids Res       Date:  1992-05-11       Impact factor: 16.971

8.  Gene transfer effects on various cationic amphiphiles in CHO cells.

Authors:  Ken-Ichi Kusumoto; Tetsuyuki Akao; Eiichi Mizuki; Osamu Nakamura
Journal:  Cytotechnology       Date:  2006-09-07       Impact factor: 2.058

9.  Advances in animal cell recombinant protein production: GS-NS0 expression system.

Authors:  L M Barnes; C M Bentley; A J Dickson
Journal:  Cytotechnology       Date:  2000-02       Impact factor: 2.058

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.